Dishman Carbogen Amcis Net Revenue stands at Rs. 541 Crores for Q1 FY23

Ahmedabad (Gujarat) [India], August 12: Dishman Carbogen Amcis Ltd, a fully integrated CRAMS (Contract Research & Manufacturing) company with strong capabilities right from process research & development to late stage clinical and commercial manufacturing and supply of API to innovator pharmaceutical companies, announces their first quarter (Q1FY23) results.

Financial performance

Consolidated Q1FY23 review

  • Net revenue was Rs. 5,406mn for Q1 FY23 as compared to Rs. 5,507mn in the corresponding period of the previous year
  • EBITDA stood at Rs. 904 mn for Q1 FY23 as compared to Rs. 1,006 mn during the corresponding period of previous year
  • EBITDA Margin at 16.7% for Q1 FY23 as against 18.3% in Q1 FY22
  • Net Profit stood at Rs. 40 mn for Q1 FY23 as compared to Rs. 160 mn in the corresponding period of the previous year 

Q1 FY23Result Highlights

  • Net Revenue at Rs 5,406 mn in Q1 FY23 down by 1.8% YoY mainly on account of lower revenues from Netherlands business.
  • Dishman Carbogen Amcis – NCE APIs and Intermediates revenue increased by 91.9% YoY primarily due to:
    • Increased supplies of APIs and intermediates from Bavla site driven by successful customer audits.
  • Dishman Carbogen Amcis – Quats and Generics revenue increased by 7.1% YoY primarily due to:
    • Increased demand for these products especially in the exports market driven by exceptional operational performance by Naroda site.
  • Carbogen Amcis – CRAMS revenue increased by 3.0% YoY primarily due to:
    • Higher Development revenue comprising 70% of the total revenue for the quarter.
  • Carbogen Amcis – Cholesterol and Vitamin D analogues revenue decreased by 46.0% YoY primarily due to:
    • Carbogen Amcis BV’s Q1FY22 revenue was almost 38% of the total year’s revenue, thus extremely front ended, which is not the case this year. One of the customers last year had stocked up huge amount of inventory in June quarter.
  • EBITDA Margin at 16.3% in Q1 FY23 compared to 18.3% in Q1 FY22 due to:
    • Higher energy costs and higher raw material costs impacted the cost base significantly in Carbogen Amcis BV in the first quarter as compared to last year same quarter.
    • Higher logistics costs have also impacted the cost base globally.
    • One time FX loss impact approximately Rs. 9.00 crores as part of “Other Expenses”

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business

An Unforgettable Evening: EO Noida’s 4th President’s Gala Shines Bright

Noida (Uttar Pradesh), July 13: On 6th July, EO Noida’s President Gala at the ITC Grand Bharat in Gurgaon. Drawing attention as a highlight on the social calendar, the annual gala combined futuristic elegance with avant-garde flair, creating a sensory feast for attendees. The evening commenced with a gourmet lunch and an energetic salsa workshop, […]

Read More
Business

Celebrate the Bond of Love with Thoughtful Rakhi Gifts from Rakhi.com

Rakhi.com launches latest rakhi collection and gift hampers New Delhi (India), July 12 : As the auspicious festival of Raksha Bandhan is coming soon, Rakhi.com is all set with their latest rakhi collection, celebrating the bond between siblings. Founded with a vision to enhance the essence of sibling love, they offer heartfelt rakhi gifts hampers embodying Raksha Bandhan’s spirit.  […]

Read More
Business

Aeterna Shower Sliding System by Hafele

New Delhi (India) July 12 : Sliding solutions optimise space and deliver enhanced functionality and aesthetics in any area of home. Introducing a shower sliding system transforms your daily routine with a space-saving, convenient solution. Meticulously crafted with precision and attention to details, Hafele’s new Aeterna Shower Sliding System exudes state-of-the-art luxury. “Aeterna,” which in […]

Read More